Segment Reporting - Operating Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Segment Reporting Information [Line Items]
Net sales	$ 384,157	$ 339,845	$ 1,121,970	$ 1,001,356
Selling, general and administrative expenses	119,801	99,644	340,384	288,657
Income from operations	42,612	37,261	130,525	119,129
Total other expense - net	(4,072)	(604)	(10,648)	(2,281)
Income before income taxes	38,540	36,657	119,877	116,848
Cardiovascular
Segment Reporting Information [Line Items]
Net sales	366,425	322,855	1,069,163	964,044
Cost of sales standard	144,299	137,530	430,449	411,088
Cost of sales other	47,324	37,531	129,057	105,661
Selling, general and administrative expenses	113,835	90,409	322,482	273,343
Research and development expenses	23,157	19,727	68,417	60,286
Other operating expenses	32	103	1,198	292
Income from operations	37,778	37,555	117,560	113,374
Endoscopy
Segment Reporting Information [Line Items]
Net sales	17,732	16,990	52,807	37,312
Cost of sales standard	4,258	4,594	12,963	10,959
Cost of sales other	1,865	2,655	6,583	3,298
Selling, general and administrative expenses	5,966	9,235	17,902	15,314
Research and development expenses	809	800	2,394	1,986
Income from operations	$ 4,834	$ (294)	$ 12,965	$ 5,755